These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 20067703)

  • 1. Drug-drug interactions associated with length of stay and cost of hospitalization.
    Moura CS; Acurcio FA; Belo NO
    J Pharm Pharm Sci; 2009; 12(3):266-72. PubMed ID: 20067703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of potential drug-drug interactions and its associated factors in a Brazilian teaching hospital.
    Cruciol-Souza JM; Thomson JC
    J Pharm Pharm Sci; 2006; 9(3):427-33. PubMed ID: 17207423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential drug-drug interactions and polypharmacy in institutionalized elderly patients in a public hospital in Brazil.
    Castilho ECD; Reis AMM; Borges TL; Siqueira LDC; Miasso AI
    J Psychiatr Ment Health Nurs; 2018 Feb; 25(1):3-13. PubMed ID: 28892271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between potential drug-drug interactions and mortality rate of elderly hospitalized patients.
    Rosas-Carrasco O; García-Peña C; Sánchez-García S; Vargas-Alarcón G; Gutiérrez-Robledo LM; Juárez-Cedillo T
    Rev Invest Clin; 2011; 63(6):564-73. PubMed ID: 23650669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential drug-drug interactions in hospitalized patients undergoing systemic chemotherapy: a prospective cohort study.
    Stoll P; Kopittke L
    Int J Clin Pharm; 2015 Jun; 37(3):475-84. PubMed ID: 25711852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and contributors to potential drug-drug interactions in hospitalized patients.
    Reimche L; Forster AJ; van Walraven C
    J Clin Pharmacol; 2011 Jul; 51(7):1043-50. PubMed ID: 20926752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentially inappropriate medications and drug-drug interactions in home-dwelling people with mild dementia.
    Oesterhus R; Aarsland D; Soennesyn H; Rongve A; Selbaek G; Kjosavik SR
    Int J Geriatr Psychiatry; 2017 Feb; 32(2):183-192. PubMed ID: 26924491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency and nature of drug-drug interactions in a Swiss primary and secondary acute care hospital.
    Oertle M
    Swiss Med Wkly; 2012; 142():w13522. PubMed ID: 22327947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with polypharmacy and the prescription of multiple medications among persons living with HIV (PLWH) compared to non-PLWH.
    Moore HN; Mao L; Oramasionwu CU
    AIDS Care; 2015; 27(12):1443-8. PubMed ID: 26608408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polypharmacy, aging and potential drug-drug interactions in outpatients in Taiwan: a retrospective computerized screening study.
    Lin CF; Wang CY; Bai CH
    Drugs Aging; 2011 Mar; 28(3):219-25. PubMed ID: 21250763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential drug-drug interactions associated with prolonged stays in the intensive care unit: a retrospective cohort study.
    Moura C; Prado N; Acurcio F
    Clin Drug Investig; 2011; 31(5):309-16. PubMed ID: 21344954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of the coprescription of clinically important interacting drug combinations involving oral anticancer agents in Singapore: a retrospective database study.
    Ko Y; Tan SL; Chan A; Wong YP; Yong WP; Ng RC; Lim SW; Salim A
    Clin Ther; 2012 Aug; 34(8):1696-704. PubMed ID: 22795926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug interactions detected by a computer-assisted prescription system in primary care patients in Spain: MULTIPAP study.
    Rogero-Blanco E; Del-Cura-González I; Aza-Pascual-Salcedo M; García de Blas González F; Terrón-Rodas C; Chimeno-Sánchez S; García-Domingo E; López-Rodríguez JA;
    Eur J Gen Pract; 2021 Dec; 27(1):90-96. PubMed ID: 33982632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential drug-drug interactions with abiraterone in metastatic castration-resistant prostate cancer patients: a prevalence study in France.
    Bonnet C; Boudou-Rouquette P; Azoulay-Rutman E; Huillard O; Golmard JL; Carton E; Noé G; Vidal M; Orvoen G; Chah Wakilian A; Villeminey C; Blanchet B; Alexandre J; Goldwasser F; Thomas-Schoemann A
    Cancer Chemother Pharmacol; 2017 May; 79(5):1051-1055. PubMed ID: 28361167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of Clinically Significant Drug-Drug Interactions Across US Children's Hospitals.
    Antoon JW; Hall M; Herndon A; Carroll A; Ngo ML; Freundlich KL; Stassun JC; Frost P; Johnson DP; Chokshi SB; Brown CM; Browning WL; Feinstein JA; Grijalva CG; Williams DJ
    Pediatrics; 2020 Nov; 146(5):. PubMed ID: 33037121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and predictors of adverse drug reactions caused by drug-drug interactions in elderly outpatients: a prospective cohort study.
    Obreli Neto PR; Nobili A; de Lyra DP; Pilger D; Guidoni CM; de Oliveira Baldoni A; Cruciol-Souza JM; de Carvalho Freitas AL; Tettamanti M; Gaeti WP; Nakamura Cuman RK
    J Pharm Pharm Sci; 2012; 15(2):332-43. PubMed ID: 22579011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential drug-drug interactions in the medication of medical patients at hospital discharge.
    Egger SS; Drewe J; Schlienger RG
    Eur J Clin Pharmacol; 2003 Mar; 58(11):773-8. PubMed ID: 12634985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inappropriate medication use among hospitalized older adults in Italy: results from the Italian Group of Pharmacoepidemiology in the Elderly.
    Onder G; Landi F; Cesari M; Gambassi G; Carbonin P; Bernabei R;
    Eur J Clin Pharmacol; 2003 Jun; 59(2):157-62. PubMed ID: 12734610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends and Determinants of Polypharmacy and Potential Drug-Drug Interactions at Discharge From Hospital Between 2009-2015.
    Abolhassani N; Castioni J; Santschi V; Waeber G; Marques-Vidal P
    J Patient Saf; 2021 Dec; 17(8):e1171-e1178. PubMed ID: 29557932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and risk of potential cytochrome P450-mediated drug-drug interactions in older hospitalized patients with polypharmacy.
    Doan J; Zakrzewski-Jakubiak H; Roy J; Turgeon J; Tannenbaum C
    Ann Pharmacother; 2013 Mar; 47(3):324-32. PubMed ID: 23482734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.